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1. Introduction 
The process of phagocytosis in polymorphonuclear 
leucocytes (PMN) is associated with a number of 
metabolic modifications of leucocytes such as increas- 
ed respiration, increased glucose oxidation through 
the hexose monophosphate shunt (HMS) and increas- 
ed production of highly reactive molecules (Hz O2 and 
0;) [l-4] A metabolic burst similar to that caused 
by phagocytosable materials can also be induced, in 
vitro, by producing a perturbation at the surface 
membrane of the cell with phospholipase C [.5], 
antileucocyte antibodies [6], endotoxins [7] , Con- 
canavalin A [8] , detergents [9] or fatty acids [IO] . 
A stimulation of leucocyte functions by non-phago- 
cytosable materials may also occur in vivo. It has been 
shown in fact that activation of the complement 
through the alternate pathway causes a stimulation of 
PMN metabolism [ 111 and induces selective exocyto- 
sis of granule enzymes in these cells [ 121. The biolo- 
gically active fragment CSa is considered to be respon- 
sible for both events [ 13,141. 
In this paper we show that the interaction between 
C3b of C567 and the cell surface of PMN plays a role 
in activating the oxidative metabolism of these cells. 
2. Materials and methods 
2.1. Separation of PMN 
Lcucocytes were separated from fresh human blood 
collected in ACD. 1 ml of 15% dextran solution (mol. 
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wt 200 000) in isotonic saline was added to 6 ml of 
blood. After sedimentation of erythrocytes, leucocytes 
were harvested by centrifugation and residual erythro- 
cytes lysed by brief exposure to hypotonic treatment. 
The differential counts gave on average the following 
percentages: PMN 80-9070, lymphocytes lo-20%, 
eosinophils 3-6%. Leucocytes were suspended in 
Hank’s balanced salt solution (HBSS). 
2.2. Determination of glucose oxidation 
The production of l4 CO* from 1-[ l4 C] - and 
6- [ l4 C] -glucose was measured as previously reported 
[I51 
2.3. Preparation of C3Sepharose 
C3-Sepharose was prepared according to Pepys et al. 
(personal communication, to be published). Briefly, 
packed Sepharose 4B (Pharmacia, Sweden), after 
washing with HBSS, was mixed with fresh human 
serum (ratio 1: 10 v/v) and incubated at 37°C for 1 hr 
with constant stirring. Control Sepharose was prepared 
by incubating the beads with serum in EDTA (0.01 M). 
C3-Sepharose and control Sepharose were extensively 
washed after incubation. The presence of C3 bound 
to Sepharose was documented with fluorescein labelled 
anti human C3 (Behringwerke, Germany). 
2.4. Preparatiorz of Con A-Sepharose 
Concanavalin A (Con A), obtained from Sigma 
Chemical Co., USA, was coupled to Sepharose 4B 
following the method described by Romeo et al. [8]. 
Trace amount of fluorescein-Con A was mixed with 
the unlabelled Con A during the process of Con A- 
Sepharose preparation to ascertain the binding of 
Con A to the beads. 
North-Holland Publishing Company - Amsterdam 
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Preparation of C.567, C.56 and C7 were separated 
from human serum according to Lachmann and 
Thompson and Thompson and Lachmann, respectively 
[16-171. 
3. Results 
The binding of C3 to Sepharose beads was detected 
at the fluorescence microscope after treatment of the 
beads with fluorescein labelled anti C3 serum. The 
fluorescence was homogeneously diffused on the surface 
of the beads. A similar pattern of labelling was detect- 
ed in Sepharose beads treated with fluoresceinated 
Con A. Table 1 shows the results of [‘“Cl-glucose 
oxidation by PMN in presence of control Sepharose 
and C3-Sepharose (ratio beads: leucocytes, 1:450). 
A five fold increase of 14COz production from 
l- [ l4 Clglucose took place when leucocytes were 
challenged with C3Sepharose, whereas the production 
of l4 COz from 6- [14 Clglucose was unchanged indica- 
ting that the increase of glucose oxidation was perform- 
ed by an enhanced activity of the hexose monophos- 
phate shunt. The challenge of PMN with control 
Sepharose did not modify the rate of the oxidation of 
either l-[‘4C]glucose or 6-[r4C]glucose. In parallel 
experiments Sepharose with Con A immobilized on 
the surface induced also an increase of l4 CO* produc- 
Table 1 
Effect of bound C3b on the stimulation of glucose oxidation 
in human polymorphonuclear leucocytes 
~___ 
counts/l5 min ___. 
l-[‘4C]glucose 6-[ “C]glucose 
-___ 
Resting PMN 6900 1250 
+ Control-Sepharose 7400 1215 
+ C3-Sepharose 32 900 1735 
The incubation mixture contained 1 x 10’ PMN, 23 x lo4 
Sepharose beads, 0.2 mg glucose, 0.5 PCi of glucose-l-[ I4 C] 
or 3.6 MCi of glucose-6-[ I4 C] The basic medium was balanc- 
ed Hank’s solution. Final volume 2 ml. Temperature 37°C. 
The center well of the flask contained 0.25 ml of 20% KOH. 
After 15 min the reaction was stopped by addition of 2 ml of 
0.5N H, SO,. After additional 30 min the content of the 
center well was transferred into vials for scintillation counting 
and counted in a LS-100 Beckman scintillation counter. Bray’s 
solution was used as the scintillation cocktail [ 231. 
Fig. 1. Rosette appearance of a mixture of human polymorpho- 
nuclear leucocytes and C3-Sepharose. 1 X lo6 PMN were 
mixed with 40-50 X lo3 beads in 0.2 ml at 37°C for lo- 15 
min. The suspension was then examined under phase micro- 
scope. 
tion from l- [ l4 C] -glucose as previously described in 
our laboratory [8]. 
Microscopic examination of a mixture of PMN and 
Sepharose revealed cell adherence to the beads covered 
with either C3 (fig.1) of Con A (not shown) in a typi- 
cal rosette appearance. No adherent leucocytes to 
control Sepharose were detected. 
The change in PMN activity induced by the interac- 
tion between C3Sepharose and leucocytes was also 
studied at different cell/beads ratios. As shown in 
fig.2 by increasing the amount of beads available to 
leucocytes a parallel enhancement of l4 CO* produc- 
tion from l- [ l4 Clghrcose was detected. 
233 
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Eig.2. Effect of varying amount of C3-Sepharose on the 
oxidation of l-[‘4C]glucose by human polymorphonuclear 
leucocytes and a comparison between the effect of C3-Se- 
pharose and that of Con-A-Sepharose on glucose oxidation. 
For details see the footnote to table 1. 
In order to gain informations about the relation- 
ship between the stimulation of HMS activity and the 
adhesion of leucocytes we compared the metabolic 
activation of leucocytes challenged with C3Sepharose 
or Con A-Sepharose. By using the same amount of 
beads coated with either C3 or Con A the number of 
leucocytes adherent to the two types of beads was 
similar whereas the stimulation induced by Con A- 
Sepharose was greater than that induced by C3Sepha- 
rose. Accordingly (tig.2), a significant increase of 
l- [’ 4 C] glucose oxidation could be obtained only by 
using about 10 X lo4 C3Sepharose beads as compared 
to the small number (15 X 103) of Con A-Sepharose 
beads that gave a two fold increase in glucose oxida- 
tion. 
Fig.3 shows that C567 markedly stimulated the 
oxidation of l- [ l4 Clglucose whereas inactivated C 567 
had only a slight effect. 
4. Discussion 
The plasma membrane of leucocytes plays an 
important role in regulating the metabolic behaviour 
234 
20 
PMN.Crn 
_, 
PMN + INACTIVATED C 567 
ON 
/ _- D 
*U 
-1 10 
P- 
RESTING PMN 
TIME MINUTES 
Fig.3. Effect of C567 and inactivated C567 on the oxidation 
of 1-[“‘Cjglucose by human polymorphonuclear leucocytes. 
C567 was inactivated by heating at 56°C for 30 min. The - 
amount of C567 of inactivated C567 that was used corre- 
sponded to 50 ng protein. Other experimental details as in the 
footnote to table 1 except that 5 X lo6 cells were used in 
each assay. 
and several other functions of these cells such as the 
recognition of foreign material, the endocytosis and 
the exocytosis [ 181. Among the various agents that 
are able to interact with the plasma membrane of 
leucocytes, thus causing metabolic stimulation of the 
cell and selective release of granule enzymes, the 
complement is particularly interesting in view of its 
biological importance. The complement fragment C5a 
has been shown to be able to stimulate both the activi- 
ty of the hexose monophosphate shunt [9] and the 
exocytosis [lo] . The latter function of PMN can also 
be activated by C3a and C567 [19]. 
This paper demonstrates that the interaction of C3b 
or C.567 with human PMN can also stimulate the 
metabolic activity of these cells. It is known that 
hydrogen peroxide (Hz 0,) and superoxide (O;,) are 
produced during stimulation of the aerobic metabo- 
lism of leucocytes [3,4,18]. These molecules play a 
key role in the oxidative damage to the surrounding 
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tissue and to leucocytes themselves. In addition the 
metabolic stimulation of leucocytes is usually accom- 
panied by release of granule constituents, that are 
regarded as the effecters of tissue injury at the site of 
the inflammatory process [20] . We have recently 
found that leucocyte granules also contain a factor 
that activates the complement through the alternate 
pathway (Tedesco et al., in preparation). Therefore 
the presence of the activated complement at the 
inflammatory site may trigger leucocytes to initiate, 
even in absence of phagocytosable material, a vicious 
circle that is likely to play a relevant role in propaga- 
ting the inflammation. The fragment C3b or other 
biologically active fragments, originating from activa- 
tion of the complement through the classical pathway 
or the alternate pathway, would stimulate the 
oxidative metabolism of PMN and the release of gran- 
ule constituents, including the complement activating 
factor, which, in turn, would cause further activation 
of the complement through the alternate pathway. 
The use of immobilized C3b on the surface of non 
phagocytosable Sepharose beads to stimulate leucocy- 
tes is also interesting from a different point of view. 
It is maintained that the respiratory stimulation of 
phagocytes challenged with phagocytosable particles 
is independent of ingestion per se, but is rather related 
to a perturbation of the plasma membrane of phago- 
cytes following contact with the particles [21,22] . 
This concept has been emphasized by the results ob- 
tained in this and in other laboratories using artificial 
models that made it possible to stimulate leucocytes 
with agents that only interact with the constituents 
of the plasma membrane [5,8,24,25]. The activation 
of glucose oxidation in leucocytes that adhere to C3- 
Sepharose by means of specific receptor sites for C3b 
is a further demonstration that the signal for the 
metabolic stimulation of PMN is generated by the ad- 
herence of these cells to the substrate regardless whe- 
ther this is phagocytosable or not. 
The mechanism whereby this regulatory function is 
exerted is unknown. The finding that the same num- 
ber of Sepharose beads coated with either Con A or 
C3b elicited a quantitatively different response, despite 
an equal number of PMN adhered to the beads, indi- 
cates that different ieceptor sites on the leucocyte 
surface are not equivalent as ‘triggers’ of the metab- 
olic stimulation. A different threshold of perturbability 
of the various molecules of the cell membrane would 
enable the cell to modulate its response according to 
the quality of the environmental stimuli. 
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